Elanco Animal Health Reports Second Quarter Results, Including Strong EPS and Gross Margin Improvement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Elanco Animal Health (ELAN) Says Postponing Dividend for Financial Flexibility - Bloomberg, Citing Call
August 13, 2019 8:22 AM EDTElanco Animal Health (NYSE: ELAN) Says Postponing Dividend for Financial Flexibility - Bloomberg, Citing Call
Elanco Animal Health (ELAN) Tops Q2 EPS by 2c, Updates FY Guidance
August 13, 2019 6:37 AM EDTElanco Animal Health (NYSE: ELAN) reported Q2 EPS of $0.28, $0.02 better than the analyst estimate of $0.26. Revenue for the quarter came in at $781.6 million versus the consensus estimate of $782.88 million.
GUIDANCE:
Elanco Animal Health sees FY2019 EPS of $1.04-$1.10, versus the... More
